Gender Male
Andreas Vente joined MerLion in 2006 in conjunction with the acquisition of Combinature Biopharm AG. Before becoming Managing Director of MerLion’s drug development subsidiary in Berlin in 2009, he was Head of Project Management and Non-clinical Development. At Combinature Biopharm, he worked as COO and held various management positions. Between
1998 and 2000, he was Head of the Laboratories of the German Resource Center for Genome Research GmbH (RZPD). Earlier, he worked as a postdoctoral fellow at the ETH, Zürich, and at the German Cancer Research Center, Heidelberg.
Andreas Vente obtained an MSc in Biology at the University of Cologne, Germany, in 1992 and a PhD at the Max Planck Institute for Plant Breeding Research, Cologne, in 1996.
